ErepoXen

Type: Product
Name: ErepoXen
First reported Jun 12 2014 - Updated Jun 12 2014 - 1 reports

Xenetic doses first patient on dialysis in Phase II trial of ErepoXen

US-based biopharmaceutical firm Xenetic Biosciences has announced that its partner, the Serum Institute of India, has started dosing patients in the second group of a Phase IIa clinical, sequential single dose trial of intravenously (IV) administered ... [Published PBR - News - Jun 12 2014]

Quotes

CEO Maguire said recently: "Our rapidly filling out product pipeline underlines the desirability of our strategy of moving the core operations of the company to the US, where the expertise and financial support is significantly more developed for biotechnology companies at our stage of growth."

More Content

All (6) | News (1) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (3)
sort by: Date | Relevance
Xenetic Biosciences Announces Ongoing Safety Da... [Published GlobeNewswire: Acquisitions News - Jun 30 2014]
Xenetic doses first patient on dialysis in Phas... [Published PBR - News - Jun 12 2014]
Xenetic Biosciences Announces Dosing of First P... [Published GlobeNewswire: Acquisitions News - Jun 11 2014]
Xenetic Biosciences Strengthens Technology Pate... [Published GlobeNewswire: Advertising News - Jun 09 2014]
Deals Of The Week Looks at The Intersection Of ... [Published The IN VIVO Blog - Jan 31 2014]
Xenetic Bio in landmark tie-up with Baxter [Published Proactiveinvestors United Kingdom RSS feed - Jan 30 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Xenetic doses first patient on dialysis in Phas... [Published PBR - News - Jun 12 2014]
US-based biopharmaceutical firm Xenetic Biosciences has announced that its partner, the Serum Institute of India, has started dosing patients in the second group of a Phase IIa clinical, sequential single dose trial of intravenously (IV) administered ...
Deals Of The Week Looks at The Intersection Of ... [Published The IN VIVO Blog - Jan 31 2014]
It’s a challenge to pick up an annual report or listen to a CEO present at a conference these days without reading or hearing something about “patients being at the center of everything we do.” But patient empowerment is a slippery concept. It means ...
1

Press Releases

sort by: Date | Relevance
Xenetic Biosciences Announces Ongoing Safety Da... [Published GlobeNewswire: Acquisitions News - Jun 30 2014]
Xenetic Biosciences Announces Dosing of First P... [Published GlobeNewswire: Acquisitions News - Jun 11 2014]
Xenetic Biosciences Strengthens Technology Pate... [Published GlobeNewswire: Advertising News - Jun 09 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.